Sandoz

In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift
Fierce Pharma
Wed, 02/22/17 - 09:44 am
Amgen
Sandoz
Supreme Court
biosimilars
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Bloomberg
Sat, 01/14/17 - 03:35 pm
Amgen
Supreme Court
Neupogen
Novartis
Sandoz
biosimilars
Novartis donates $10M in generics to global relief
BioPharma Dive
Mon, 11/28/16 - 11:29 pm
Novartis
generics
philanthropy
Sandoz
Novartis May Be Too Generic
TheStreet.com
Fri, 10/21/16 - 11:39 am
Novartis
generics
patents
Sandoz
Generics creep in as Teva loses two Copaxone patents
BioPharma Dive
Fri, 08/26/16 - 09:55 am
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
generics
Glatopa
Novartis
Sandoz
Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales
Fierce Pharma
Wed, 07/13/16 - 06:22 pm
Sandoz
Novartis
FDA
advisory panels
biosimilars
Enbrel
Amgen
FDA, Sandoz Prevail at D.C. Circuit on Generic FUSILEV Approval
FDA Law Blog
Mon, 06/6/16 - 11:12 pm
FDA
Sandoz
Fusilev
generics
Novartis CEO eyes biosimilar plays in Asia that fit with Sandoz plans
Fierce Pharma
Fri, 06/3/16 - 09:53 am
Novartis
Pharma CEOs
Joe Jimenez
Asia
Sandoz
biosimilars
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Fierce Pharma
Thu, 03/31/16 - 09:39 pm
Supreme Court
Sandoz
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Novartis finds buyer to save 270 jobs at German plant
Fierce Pharma
Thu, 02/25/16 - 03:15 pm
Novartis
Sandoz
layoffs
Germany
drug manufacturing
Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches
Fierce Pharma
Sat, 02/20/16 - 09:22 am
Sandoz
generics
Supreme Court
exclusivity
biosimilars
Zarxio
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
FDA Law Blog
Wed, 02/17/16 - 11:33 am
Sandoz
FDA
BPCIA
Amgen
Zarxio
Neupogen
EU agency accepts Sandoz application for pegfilgrastim biosimilar
Yahoo/Reuters
Thu, 02/11/16 - 09:16 am
Europe
Sandoz
Novartis
biosimilars
pegfilgrastim
Neulasta
Novartis: Study shows copycat works just as well as Amgen drug
Yahoo/Reuters
Mon, 12/7/15 - 12:10 pm
Novartis
Amgen
Neulasta
Sandoz
generics
breast cancer
Novartis biosimilar takes aim at Amgen drug Neulasta
Yahoo/Reuters
Wed, 11/18/15 - 09:30 am
Novartis
Amgen
biosimilars
Neulasta
Sandoz
Novartis biosimilar copycat takes aim at Amgen's drug Enbrel
Yahoo/Reuters
Fri, 10/2/15 - 10:37 am
Novartis
biosimilar
Amgen
Enbrel
rheumatoid arthritis
Sandoz
An update on first-ever US biosim Zarxio 2 weeks after its debut
BioPharma Dive
Fri, 09/18/15 - 11:42 am
Novartis
Sandoz
Zarxio
bioimilars
Amgen
Neupogen
First 'biosimilar' drug launches in the US, years after other countries
Yahoo/AP
Thu, 09/10/15 - 06:04 pm
biosimilars
Sandoz
Zarxio
Neupogen
Amgen
Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Sandoz
Zarxio
biosimilars
Novartis
drug launches
Amgen
Neupogen

Pages